NMNAT2 antibody
Quick Overview for NMNAT2 antibody (ABIN1169223)
Target
See all NMNAT2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- Recognizes human NMNAT2. Detects a band of ~35 kDa by Western blot. Not tested in other species.
-
Cross-Reactivity
- Human
-
Cross-Reactivity (Details)
- Not tested in other species.
-
Sterility
- 0.2 μm filtered
-
Immunogen
- Recombinant human NMNAT2.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives.
-
Preservative
- Without preservative
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Short Term Storage: +4°C
Long Term Storage: -20°C
Stable for at least 6 months after receipt when stored at -20°C. -
Expiry Date
- 6 months
-
-
- NMNAT2 (Nicotinamide Nucleotide Adenylyltransferase 2 (NMNAT2))
-
Alternative Name
- NMNAT2
-
Background
- NMNAT2 catalyzes the formation of NAD+ from nicotinamide mononucleotide (NMN) and ATP. Can also use the deamidated form nicotinic acid mononucleotide (NaMN) as a substrate but with lower efficiency. Also catalyzes the reverse reaction, i.e. the pyrophosphorolytic cleavage of NAD+. Highly expressed in brain, in particular in cerebrum, cerebellum, occipital lobe, frontal lobe, temporal lobe and putamen. Also found in the heart, skeletal muscle, pancreas and islets of Langerhans. Has been shown to correlate with Alzheimer's disease in APPswe/PS1dE9 transgenic mice and delayed wallerian degeneration in cultured superior cervical ganglia (SCGs) from morphological changes, microtubule destruction and neurofilament degradation.
-
UniProt
- Q9BZQ4
Target
-